Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

NCT00004024 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: autologous tumor cell vaccine
BIOLOGICAL: muromonab-CD3
BIOLOGICAL: sargramostim
BIOLOGICAL: therapeutic autologous lymphocytes
PROCEDURE: surgical procedure
RADIATION: radiation therapy

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]